Literature DB >> 26117256

Improved sensitivity to venom specific-immunoglobulin E by spiking with the allergen component in Japanese patients suspected of Hymenoptera venom allergy.

Naruo Yoshida1, Hirokuni Hirata2, Mineaki Watanabe1, Kumiya Sugiyama3, Masafumi Arima4, Yasutsugu Fukushima3, Yoshiki Ishii1.   

Abstract

BACKGROUND: Ves v 5 and Pol d 5, which constitute antigen 5, are recognized as the major, most potent allergens of family Vespidae. Several studies have reported the diagnostic sensitivity of the novel recombinant (r)Ves v 5 and rPol d 5 allergens in routine clinical laboratory settings by analyzing a group of Vespula and Polistes venom-allergic patients. In this study, we analyzed the sensitivity to venom specific (s)IgE by spiking with rVes v 5 and rPol d 5 in Japanese patients suspected of Hymenoptera venom allergy.
METHODS: Subjects were 41 patients who had experienced systemic reactions to hornet and/or paper wasp stings. Levels of serum sIgE against hornet and paper wasp venom by spiking with rVes v 5 and rPold d 5, respectively, as improvement testing, compared with hornet and paper wasp venom, as conventional testing, were measured by ImmunoCAP.
RESULTS: Of the 41 patients, 33 (80.5%) were positive (≥0.35 UA/ml) for hornet and/or paper wasp venom in conventional sIgE testing. sIgE levels correlated significantly (P < 0.01) between hornet (R = 0.92) or paper wasp venom (R = 0.78) in improvement testing and conventional testing. To determine specificity, 20 volunteers who had never experienced a Hymenoptera sting were all negative for sIgE against these venoms in both improvement and conventional testing. Improved sensitivity was seen in 8 patients negative for sIgE against both venoms in conventional testing, while improvement testing revealed sIgE against hornet or paper wasp venom in 5 (total 38 (92.7%)) patients.
CONCLUSIONS: The measurement of sIgE following spiking of rVes v 5 and rPol d 5 by conventional testing in Japanese subjects with sIgE against hornet and paper wasp venom, respectively, improved the sensitivity for detecting Hymenoptera venom allergy. Improvement testing for measuring sIgE levels against hornet and paper wasp venom has potential for serologically elucidating Hymenoptera allergy in Japan.
Copyright © 2015 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hymenoptera venom; Specific IgE; Spiking; rPol d 5; rVes v 5

Mesh:

Substances:

Year:  2015        PMID: 26117256     DOI: 10.1016/j.alit.2015.01.008

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  4 in total

Review 1.  Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.

Authors:  Angelika Tscheppe; Heimo Breiteneder
Journal:  Int Arch Allergy Immunol       Date:  2017-05-04       Impact factor: 2.749

Review 2.  Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy.

Authors:  Simon Blank; Murilo Luiz Bazon; Johannes Grosch; Carsten B Schmidt-Weber; Márcia Regina Brochetto-Braga; Maria Beatrice Bilò; Thilo Jakob
Journal:  Curr Allergy Asthma Rep       Date:  2020-07-09       Impact factor: 4.806

3.  Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure.

Authors:  Alexander Zink; Barbara Schuster; Julia Winkler; Kilian Eyerich; Ulf Darsow; Knut Brockow; Bernadette Eberlein; Tilo Biedermann
Journal:  World Allergy Organ J       Date:  2019-06-28       Impact factor: 4.084

Review 4.  Wasp Venom Biochemical Components and Their Potential in Biological Applications and Nanotechnological Interventions.

Authors:  Aida Abd El-Wahed; Nermeen Yosri; Hanem H Sakr; Ming Du; Ahmed F M Algethami; Chao Zhao; Ahmed H Abdelazeem; Haroon Elrasheid Tahir; Saad H D Masry; Mohamed M Abdel-Daim; Syed Ghulam Musharraf; Islam El-Garawani; Guoyin Kai; Yahya Al Naggar; Shaden A M Khalifa; Hesham R El-Seedi
Journal:  Toxins (Basel)       Date:  2021-03-12       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.